{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:20Z","timestamp":1792785020862,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH NCI","award":["P01CA272222"],"award-info":[{"award-number":["P01CA272222"]}]},{"name":"NIH NCI","award":["P01CA272222"],"award-info":[{"award-number":["P01CA272222"]}]},{"DOI":"10.13039\/100006239","name":"Society of Nuclear Medicine and Molecular Imaging","doi-asserted-by":"crossref","award":["2023 SNMMI Molecular Imaging Research Grant for Junior Academic Faculty"],"award-info":[{"award-number":["2023 SNMMI Molecular Imaging Research Grant for Junior Academic Faculty"]}],"id":[{"id":"10.13039\/100006239","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alpha-emitter radiopharmaceutical therapy delivers highly localized radiation, offering potent therapeutic effects. However, microscale heterogeneity remains poorly characterized in vivo and may affect efficacy. This underscores the critical need for sub-organ dosimetry to better understand \u03b1RPT radiobiology and guide treatment optimization. While autoradiography enables high-resolution activity mapping, conventional approaches lack anatomical context for accurate dose mapping. To address this, we propose a comprehensive workflow integrating quantitative autoradiography with histological imaging. Tissues from \u03b1RPT-treated mice bearing HER2\u2009+\u2009breast tumors were snap-frozen, sectioned, and imaged using autoradiography. The same sections were histologically stained and used for precise autoradiography-histology integration. These anatomical contexts were then used to accurately stack multiple sections in a 3D volume, and were used for subsequent microscale dosimetry. Both tumor and kidney tissues were analyzed. Snap-freezing in isopentane preserved tissue morphology optimally. Our method enabled precise activity localization, revealing significant accumulation in the kidney cortex region close to glomeruli. Anatomical context improved 3D reconstructions needed for accurate dose estimations in tumor tissue. This methodology enhances \u03b1RPT dosimetry by precise spatial mapping of autoradiography unto the underlying tissue morphology. These advancements provide crucial insights into \u03b1RPT spatial radiobiology at the near-cellular level and will aid in optimizing radiopharmaceutical design and treatment planning.<\/jats:p>","DOI":"10.1038\/s41598-025-09277-4","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T07:11:07Z","timestamp":1755155467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhanced activity localization and microscale dosimetry in alpha-emitter radiopharmaceutical therapy using integrated autoradiography and histological imaging"],"prefix":"10.1038","volume":"15","author":[{"given":"Sandeep","family":"Sahota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal A.","family":"Quirindongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Deveauxbray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenechukwu C.","family":"Charles-Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sgouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-3229","authenticated-orcid":false,"given":"Remco","family":"Bastiaannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"9277_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamaoncol.2016.4166","volume":"3","author":"S Salas-Vega","year":"2017","unstructured":"Salas-Vega, S., Iliopoulos, O. & Mossialos, E. Assessment of overall survival, quality of life, and safety benefits associated with new Cancer medicines. JAMA Oncol. 3, 382 (2017).","journal-title":"JAMA Oncol."},{"key":"9277_CR2","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold, M. et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 20, 1493\u20131505 (2019).","journal-title":"Lancet Oncol."},{"key":"9277_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/j.semnuclmed.2020.02.004","volume":"50","author":"C Kratochwil","year":"2020","unstructured":"Kratochwil, C., Haberkorn, U. & Giesel, F. L. 225Ac-PSMA-617 for therapy of prostate Cancer. Semin Nucl. Med. 50, 133\u2013140 (2020).","journal-title":"Semin Nucl. Med."},{"key":"9277_CR4","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","volume":"57","author":"C Kratochwil","year":"2016","unstructured":"Kratochwil, C. et al. 225Ac-PSMA-617 for PSMA-targeted a-radiation therapy of metastatic castration-resistant prostate cancer. J. Nucl. Med. 57, 1941\u20131944 (2016).","journal-title":"J. Nucl. Med."},{"key":"9277_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2967\/jnumed.120.251017","volume":"62","author":"MJ Zacherl","year":"2021","unstructured":"Zacherl, M. J. et al. First clinical results for PSMA-Targeted \u03b1-Therapy using 225Ac-PSMA-I&T in Advanced-mCRPC patients. J. Nucl. Med. 62, 669\u2013674 (2021).","journal-title":"J. Nucl. Med."},{"key":"9277_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fonc.2013.00324","volume":"3","author":"J Elgqvist","year":"2014","unstructured":"Elgqvist, J., Frost, S., Pouget, J. P. & Albertsson, P. The potential and hurdles of targeted alpha Therapy \u2013 Clinical trials and beyond. Front. Oncol. 3, 324 (2014).","journal-title":"Front. Oncol."},{"key":"9277_CR7","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1158\/1078-0432.CCR-18-3295","volume":"25","author":"R Ladjohounlou","year":"2019","unstructured":"Ladjohounlou, R. et al. Drugs that modify cholesterol metabolism alter the p38\/JNK-mediated targetedand nontargeted response to alpha and Auger radioimmunotherapy. Clin. Cancer Res. 25, 4775\u20134790 (2019).","journal-title":"Clin. Cancer Res."},{"key":"9277_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1874471011104030266","volume":"4","author":"N Chouin","year":"2012","unstructured":"Chouin, N. & Bardies, M. Alpha-Particle microdosimetry. Curr. Radiopharmaceuticalse. 4, 266\u2013280 (2012).","journal-title":"Curr. Radiopharmaceuticalse"},{"key":"9277_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.rpor.2014.10.006","volume":"21","author":"GA Santa Cruz","year":"2016","unstructured":"Santa Cruz, G. A. & Microdosimetry Principles and applications. Rep. Practical Oncol. Radiotherapy. 21, 135\u2013139 (2016).","journal-title":"Rep. Practical Oncol. Radiotherapy"},{"key":"9277_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1118\/1.596770","volume":"19","author":"TG Stinchcomb","year":"1992","unstructured":"Stinchcomb, T. G. & Roeske, J. C. Analytic microdosimetry for radioimmunotherapeutic alpha emitters. Med. Phys. 19, 1385\u20131393 (1992).","journal-title":"Med. Phys."},{"key":"9277_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-023-03991-1","volume":"21","author":"R Bastiaannet","year":"2023","unstructured":"Bastiaannet, R., Liatsou, I., Hobbs, F., Sgouros, G. & R. & Large-scale in vitro microdosimetry via live cell microscopy imaging: implications for radiosensitivity and RBE evaluations in alpha-emitter radiopharmaceutical therapy. J. Transl Med. 21, 1\u201314 (2023).","journal-title":"J. Transl Med."},{"key":"9277_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1667\/0033-7587(2001)155[0288:RWAPEM]2.0.CO;2","volume":"155","author":"Y Kvinnsland","year":"2001","unstructured":"Kvinnsland, Y., Stokke, T. & Aurlien, E. Radioimmunotherapy with alpha-particle emitters: microdosimetry of cell with a heterogeneous antigen expression and with various diameters of cells and nuclei. Radiat. Res. 155, 288\u2013296 (2001).","journal-title":"Radiat. Res."},{"key":"9277_CR13","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.110.077578","volume":"51","author":"T B\u00e4ck","year":"2010","unstructured":"B\u00e4ck, T. & Jacobsson, L. The \u03b1-camera: A quantitative digital autoradiography technique using a charge-coupled device for ex vivo high-resolution bioimaging of \u03b1-particles. J. Nucl. Med. 51, 1616\u20131623 (2010).","journal-title":"J. Nucl. Med."},{"key":"9277_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0283-2","author":"A Gustafsson-Lutz","year":"2017","unstructured":"Gustafsson-Lutz, A. et al. Therapeutic efficacy of \u03b1-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. EJNMMI Res. https:\/\/doi.org\/10.1186\/s13550-017-0283-2 (2017).","journal-title":"EJNMMI Res."},{"key":"9277_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nima.2014.05.070","volume":"767","author":"BW Miller","year":"2014","unstructured":"Miller, B. W. et al. The iQID camera: an ionizing-radiation quantum imaging detector. Nucl. Instrum. Methods Phys. Res. A. 767, 146\u2013152 (2014).","journal-title":"Nucl. Instrum. Methods Phys. Res. A"},{"key":"9277_CR16","doi-asserted-by":"crossref","unstructured":"Peter, R. et al. Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system. Sci Rep 12 (2022).","DOI":"10.1038\/s41598-022-22664-5"},{"key":"9277_CR17","doi-asserted-by":"crossref","unstructured":"Peter, R. et al. 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer. Sci Rep 14 (2024).","DOI":"10.1038\/s41598-024-70417-3"},{"key":"9277_CR18","first-page":"1087","volume":"120","author":"DA Novis","year":"1996","unstructured":"Novis, D. A., Gephardt, G. N. & Zarbo, R. J. Interinstitutional comparison of frozen section consultation in small hospitals: A college of American pathologists Q-Probes study of 18532 frozen section consultation diagnoses in 233 small hospitals. Arch. Pathol. Lab. Med. 120, 1087\u20131093 (1996).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"9277_CR19","first-page":"133","volume":"15","author":"WH Marshall","year":"1940","unstructured":"Marshall, W. H. An application of the frozen sectioning technic for cutting serial sections thru the brain. Biotech. Histochem. 15, 133\u2013138 (1940).","journal-title":"Biotech. Histochem."},{"key":"9277_CR20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1177\/34.10.3745909","volume":"34","author":"DL Rosene","year":"1986","unstructured":"Rosene, D. L., Roy, N. J. & Davis, B. J. A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifact. J. Histochem. Cytochem. 34, 1301\u20131315 (1986).","journal-title":"J. Histochem. Cytochem."},{"key":"9277_CR21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/B978-0-12-185255-9.50026-2","volume":"3","author":"DL Rosene","year":"1990","unstructured":"Rosene, D. L. & Rhodes, K. J. Cryoprotection and freezing methods to control ice crystal artifact in frozen sections of fixed and unfixed brain tissue. Methods Neurosci. 3, 360\u2013385 (1990).","journal-title":"Methods Neurosciences"},{"key":"9277_CR22","doi-asserted-by":"publisher","unstructured":"Marstal, K., Berendsen, F., Staring, M. & Klein, S. SimpleElastix: A User-Friendly, Multi-lingual library for medical image registration. IEEE Comput. Soc. Conf. Comput. Vis. Pattern Recognit. Workshops. 574\u2013582 https:\/\/doi.org\/10.1109\/CVPRW.2016.78 (2016).","DOI":"10.1109\/CVPRW.2016.78"},{"key":"9277_CR23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1109\/TPAMI.1987.4767965","volume":"PAMI-9","author":"KS Arun","year":"1987","unstructured":"Arun, K. S., Huang, T. S. & Blostein, S. D. Least-Squares fitting of two 3-D point sets. IEEE Trans. Pattern Anal. Mach. Intell. PAMI-9, 698\u2013700 (1987).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"9277_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0165530","volume":"11","author":"KN Elfer","year":"2016","unstructured":"Elfer, K. N. et al. DRAQ5 and Eosin (\u2018D&E\u2019) as an analog to hematoxylin and Eosin for rapid fluorescence histology of fresh tissues. PLoS One. 11, 1\u201318 (2016).","journal-title":"PLoS One"},{"key":"9277_CR25","first-page":"880","volume":"61","author":"RT Reilly","year":"2001","unstructured":"Reilly, R. T. et al. The collaboration of both humoral and cellular HER-2\/neu-targeted immune responses is required for the complete eradication of HER-2\/neu-expressing tumors. Cancer Res. 61, 880\u2013883 (2001).","journal-title":"Cancer Res."},{"key":"9277_CR26","first-page":"3569","volume":"60","author":"RT Reilly","year":"2000","unstructured":"Reilly, R. T. et al. HER-2\/neu is a tumor rejection target in tolerized HER-2\/neu Transgenic mice. Cancer Res. 60, 3569\u20133576 (2000).","journal-title":"Cancer Res."},{"key":"9277_CR27","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-07-4672","volume":"14","author":"H Song","year":"2008","unstructured":"Song, H. et al. An immunotolerant HER-2\/neu Transgenic mouse model of metastatic breast cancer. Clin. Cancer Res. 14, 6116\u20136124 (2008).","journal-title":"Clin. Cancer Res."},{"key":"9277_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ijrobp.2023.06.003","volume":"117","author":"I Liatsou","year":"2023","unstructured":"Liatsou, I. et al. Early normal tissue effects and bone marrow relative biological effectiveness for an actinium 225-Labeled HER2\/neu-Targeting antibody. Int. J. Radiat. Oncol. Biol. Phys. 117, 1028\u20131037 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"9277_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2967\/jnumed.106.036020","volume":"48","author":"M Gotthardt","year":"2007","unstructured":"Gotthardt, M. et al. Indication for different mechanisms of kidney uptake of radiolabeled peptides. J. Nucl. Med. 48, 596\u2013601 (2007).","journal-title":"J. Nucl. Med."},{"key":"9277_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/ph17020256","volume":"17","author":"KE de Roode","year":"2024","unstructured":"de Roode, K. E., Joosten, L. & Behe, M. Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands. Pharmaceuticals 17, 256 (2024).","journal-title":"Pharmaceuticals"},{"key":"9277_CR31","doi-asserted-by":"publisher","unstructured":"Vegt, E. et al. Renal toxicity of radiolabeled peptides and antibody fragments: Mechanisms, impact on radionuclide therapy, and strategies for prevention. Journal of Nuclear Medicine 51, 1049\u20131058. https:\/\/doi.org\/10.2967\/jnumed.110.075101 (2010).","DOI":"10.2967\/jnumed.110.075101"},{"key":"9277_CR32","doi-asserted-by":"crossref","unstructured":"Lowekamp, B. C., Chen, D. T., Ib\u00e1\u00f1ez, L. & Blezek, D. The design of simpleitk. Front Neuroinform 7 (2013).","DOI":"10.3389\/fninf.2013.00045"},{"key":"9277_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Otsu","year":"1979","unstructured":"Otsu, N. A threshold selection method from Gray-Level histograms. IEEE Trans. Syst. Man. Cybern. 9, 62\u201366 (1979).","journal-title":"IEEE Trans. Syst. Man. Cybern"},{"key":"9277_CR34","doi-asserted-by":"publisher","unstructured":"\u00d6rbom, A., Miller, B. W. & B\u00e4ck, T. Beta and alpha particle autoradiography. Handb. Nuclear Med. Mol. Imaging Physicists. 563\u2013587. https:\/\/doi.org\/10.1201\/9780429489556-30 (2022).","DOI":"10.1201\/9780429489556-30"},{"key":"9277_CR35","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1158\/1078-0432.CCR-16-2955","volume":"23","author":"MI Suominen","year":"2017","unstructured":"Suominen, M. I. et al. Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models. Clin. Cancer Res. 23, 4335\u20134346 (2017).","journal-title":"Clin. Cancer Res."},{"key":"9277_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nucmedbio.2018.05.003","volume":"62\u201363","author":"W Jiang","year":"2018","unstructured":"Jiang, W., Ulmert, D., Simons, B. W., Abou, D. S. & Thorek, D. L. J. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates. Nucl. Med. Biol. 62\u201363, 1\u20138 (2018).","journal-title":"Nucl. Med. Biol."},{"key":"9277_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2967\/jnumed.123.266571","volume":"65","author":"N Benabdallah","year":"2024","unstructured":"Benabdallah, N. et al. Beyond average: a-Particle distribution and dose heterogeneity in bone metastatic prostate Cancer. J. Nucl. Med. 65, 245\u2013251 (2024).","journal-title":"J. Nucl. Med."},{"key":"9277_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jnci\/djv380","volume":"108","author":"DS Abou","year":"2016","unstructured":"Abou, D. S. et al. Whole-Body and microenvironmental localization of Radium-223 in Na\u00efve and mouse models of prostate Cancer metastasis. JNCI J. Natl. Cancer Inst. 108, 380 (2016).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"9277_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-020-0600-z","volume":"10","author":"TA B\u00e4ck","year":"2020","unstructured":"B\u00e4ck, T. A. et al. Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors. EJNMMI Res. 10, 1\u201312 (2020).","journal-title":"EJNMMI Res."},{"key":"9277_CR40","doi-asserted-by":"publisher","first-page":"100873","DOI":"10.1016\/j.tranon.2020.100873","volume":"14","author":"S Palm","year":"2021","unstructured":"Palm, S. et al. Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer. Transl Oncol. 14, 100873 (2021).","journal-title":"Transl Oncol."},{"key":"9277_CR41","doi-asserted-by":"publisher","unstructured":"Lu, P. et al. Blind image restoration enhances digital autoradiographic imaging of radiopharmaceutical tissue distribution. J. Nuclear Med. https:\/\/doi.org\/10.2967\/jnumed.121.262270 (2021).","DOI":"10.2967\/jnumed.121.262270"},{"key":"9277_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1118\/1.2828198","volume":"35","author":"M Zhang","year":"2008","unstructured":"Zhang, M. et al. Image Deconvolution in digital autoradiography: A preliminary study. Med. Phys. 35, 522 (2008).","journal-title":"Med. Phys."},{"key":"9277_CR43","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1364\/OE.26.005478","volume":"26","author":"FE Sahin","year":"2018","unstructured":"Sahin, F. E. & Tanguay, A. R. Distortion optimization for wide-angle computational cameras. Opt. Express. 26, 5478 (2018).","journal-title":"Opt. Express"},{"key":"9277_CR44","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1364\/AO.456127","volume":"61","author":"Z Zhuang","year":"2022","unstructured":"Zhuang, Z., Parent, J., Roulet, P. & Thibault, S. Freeform wide-angle camera lens enabling mitigable distortion. Appl. Opt. 61, 5449 (2022).","journal-title":"Appl. Opt."},{"key":"9277_CR45","doi-asserted-by":"publisher","unstructured":"Barbier, O., Jacquillet, G., Tauc, M., Cougnon, M. & Poujeol, P. Effect of heavy metals on, and handling by, the kidney. Nephron - Physiology. https:\/\/doi.org\/10.1159\/000083981 (2005).","DOI":"10.1159\/000083981"},{"key":"9277_CR46","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.1158\/0008-5472.CAN-09-1828","volume":"69","author":"H Song","year":"2010","unstructured":"Song, H. et al. Radioimmunotherapy of breast Cancer metastases with Alpha- Particle-emitter 225 ac: comparing efficacy with 213 bi, 90 Y Hong. Cancer Res. 69, 8941\u20138948 (2010).","journal-title":"Cancer Res."},{"key":"9277_CR47","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/jlcr.3628","volume":"61","author":"D Vivier","year":"2018","unstructured":"Vivier, D., Sharma, S. K. & Zeglis, B. M. Understanding the in vivo fate of radioimmunoconjugates for nuclear imaging. J. Label. Comp. Radiopharm. 61, 672\u2013692 (2018).","journal-title":"J. Label. Comp. Radiopharm"},{"key":"9277_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.30443","author":"J Stabinska","year":"2025","unstructured":"Stabinska, J. et al. MRI detects tubulointerstitial changes in mouse models of radiation-induced nephropathy. Magn. Reson. Med. https:\/\/doi.org\/10.1002\/mrm.30443 (2025).","journal-title":"Magn. Reson. Med."},{"key":"9277_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1088\/0031-9155\/40\/1\/014","volume":"40","author":"JL Humm","year":"1995","unstructured":"Humm, J. L. et al. The Spatial accuracy of cellular dose estimates obtained from 3D reconstructed serial tissue autoradiographs. Phys. Med. Biol. 40, 163\u2013180 (1995).","journal-title":"Phys. Med. Biol."},{"key":"9277_CR50","first-page":"1811","volume":"34","author":"JL Humm","year":"1993","unstructured":"Humm, J. L., Macklis, R. M., Bump, K., Cobb, L. M. & Chin, L. M. Internal dosimetry using data derived from autoradiographs. J. Nucl. Med. 34, 1811\u20131817 (1993).","journal-title":"J. Nucl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09277-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:19:31Z","timestamp":1757456371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09277-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9277"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09277-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B. W. Miller is founder of QScint Imaging Solutions, LLC, which has commercialized the iQID camera for digital autoradiography applications. R.F.H. receives royalties pertaining to IP licensed to Radiopharmaceutical Imaging and Dosimetry , LLC (Rapid) and is consultant for Vivos, Varian, Novartis, Boston Scientific, AstraZeneca, and Mirion, none of which pertains to the contents of this manuscript. Author G.S. is a consultant for Bayer, PointBiopharma, Precirix, RayzeBio, Actinium Pharmaceuticals, is on the scientific advisory board for Orano Med, Convergent Therapeutics, Nucleus Radiopharma, and Radiomedix. He is a founder and stakeholder of Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid). None of these potentially competing interests pertain to the work presented in this manuscript.All other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29807"}}